Loading clinical trials...
Loading clinical trials...
Multicenter Phase II Trial of Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With no Squamous Non Small Cell Lung Cancer Refractory to First Line Chemotherapy
Conditions
Interventions
vargatef®
Docetaxel
Locations
11
France
CH de Beauvais
Beauvais, France
CHU Brest
Brest, France
Service de Pneumologie
Créteil, France
Service de Pneumologie
Gap, France
CHU de Limoges
Limoges, France
CH de Bretagne Sud
Lorient, France
Start Date
September 1, 2015
Primary Completion Date
September 26, 2020
Completion Date
September 26, 2020
Last Updated
August 10, 2021
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT04631770
Lead Sponsor
University Hospital, Limoges
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions